These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38149692)

  • 1. Pharmaceutical industry-sponsored meals are associated with increased prescriptions and Medicare spending for dupilumab among dermatologists in the United States.
    Murayama A
    J Eval Clin Pract; 2024 Apr; 30(3):435-439. PubMed ID: 38149692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry-sponsored meal payments are associated with prescriptions and Medicare expenditures on brand-name colchicine in the United States.
    Murayama A
    Int J Rheum Dis; 2024 Jan; 27(1):e14962. PubMed ID: 37923570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.
    Hartung DM; Johnston K; Cohen DM; Nguyen T; Deodhar A; Bourdette DN
    JAMA Netw Open; 2018 Jun; 1(2):e180482. PubMed ID: 30646086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States.
    Murayama A; Marshall DC
    Gynecol Oncol; 2024 Feb; 181():83-90. PubMed ID: 38147713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Pharmaceutical Industry Payments to Physicians With Prescription and Medicare Expenditures for Pimavanserin.
    Mehta HB; Moore TJ; Alexander GC
    Psychiatr Serv; 2021 Jan; 72(1):77-80. PubMed ID: 32838675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology.
    Duarte-García A; Crowson CS; McCoy RG; Herrin J; Lam V; Putman MS; Ross JS; Matteson EL; Shah ND
    Mayo Clin Proc; 2022 Feb; 97(2):250-260. PubMed ID: 35120693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Payments from Pharmaceutical Companies Related to Cancer Drugs.
    Mitchell AP; Mishra Meza A; Trivedi NU; Bach PB; Gönen M
    Oncologist; 2022 Oct; 27(10):857-863. PubMed ID: 35946837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching.
    Inoue K; Tsugawa Y; Mangione CM; Duru OK
    PLoS Med; 2021 Jun; 18(6):e1003645. PubMed ID: 34061852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between industry payments for opioid products and physicians' prescription of opioids: observational study with propensity-score matching.
    Inoue K; Figueroa JF; Orav EJ; Tsugawa Y
    J Epidemiol Community Health; 2020 Aug; 74(8):647-654. PubMed ID: 32350126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
    Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
    PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Industry-Dermatologist Financial Relationship: Insight From the Open Payment Data.
    Feng H; Wu P; Leger M
    JAMA Dermatol; 2016 Dec; 152(12):1307-1313. PubMed ID: 27706478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States.
    Inoue K; Figueroa JF; DeJong C; Tsugawa Y; Orav EJ; Shen C; Kazi DS
    Circ Cardiovasc Qual Outcomes; 2021 May; 14(5):e007521. PubMed ID: 33966446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.
    Bandari J; Ayyash OM; Turner RM; Jacobs BL; Davies BJ
    Cancer; 2017 Nov; 123(22):4356-4362. PubMed ID: 28749536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
    Morse E; Hanna J; Mehra S
    Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry payments and physicians prescriptions: Effect of a payment restriction policy.
    Ansari B
    Soc Sci Med; 2021 Jun; 278():113942. PubMed ID: 33892242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Industry Payments to Physicians for Antiplatelet Drugs and Utilization of Cardiac Procedures and Stents.
    Yanagisawa M; Blumenthal DM; Kato H; Inoue K; Tsugawa Y
    J Gen Intern Med; 2022 May; 37(7):1626-1633. PubMed ID: 34378113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
    Zezza MA; Bachhuber MA
    PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.